The Emirates Drug Establishment (EDE) has carried out more than 568 inspections of medical warehouses across the country since the beginning of the year, including 86 inspections in March, as part of efforts to secure medicine stockpile.
The inspection findings help monitor medicine movement and support decision-making, while ensuring compliance with storage, transport and regulatory standards, while promoting best practices.
Dr. Fatima Al Kaabi, Director-General of the EDE, said drug security remains a national priority, with a focus on ensuring the availability, safety and quality of medicines while supporting the development of the domestic pharmaceutical sector.
Faris Almaazmi, Director of Inspection and Control Department at the EDE, said inspection teams operate under regular oversight programmes and risk-based inspection methodologies, while also monitoring medicine movements within warehouses and verifying the accuracy of documentation and traceability procedures to promote compliance among pharmaceutical establishments.
Pharmaceutical market data indicate stable and reassuring levels of medicine availability, underpinned by a secure and sufficient strategic stockpile covering local demand for extended periods, and supported by advanced regulatory capabilities that enhance the efficiency and resilience of the pharmaceutical ecosystem.
EDE said it will continue to expand the use of digital tools and data analytics to strengthen oversight, improve efficiency and support market stability and reinforce drug security in the UAE.

UAE ministry confirms 10 Emiratis, 4 Indians killed in Fujairah crash
Dubai Police dismantles investment fraud network
Public Prosecution launches investigation into Fujairah crash
Eid Al Etihad holidays confirmed for private sector
Prison terms, heavy fines for those involved in Abu Dhabi hotel brawl
UAE President, Arab League chief discuss regional developments
Dubai Police issues over 27,000 traffic fines in October
UAE announces Eid Al Etihad holidays for federal sector
